# A Study to Learn if Study Medicines Called Cyclosporine and Clarithromycin Affect How the Body Processes the Other Study Medicine Called PF-07328948 in Healthy Adults

> **NCT06837259** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 26 (actual)

## Conditions studied

- Healthy Adults

## Interventions

- **DRUG:** PF-07328948
- **DRUG:** cyclosporine
- **DRUG:** clarithromycin

## Key facts

- **NCT ID:** NCT06837259
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-03-19
- **Primary completion:** 2025-06-11
- **Final completion:** 2025-06-11
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2026-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06837259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06837259, "A Study to Learn if Study Medicines Called Cyclosporine and Clarithromycin Affect How the Body Processes the Other Study Medicine Called PF-07328948 in Healthy Adults". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT06837259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
